Development of radioiodinated nucleoside analogs for imaging tissue proliferation: Comparisons of six 5-iodonucleosides

Nuclear Medicine and Biology

Volumn 30, Issue 7, 2003, Pages 687-696

  Toyohara, Jun ^a,c   Hayashi, Akio ^a   Sato, Mikiko ^a   Gogami, Akie ^a   Tanaka, Hiromichi ^b   Haraguchi, Kazuhiro ^b   Yoshimura, Yuichi ^b   Kumamoto, Hiroki ^b   Yonekura, Yoshiharu ^c   Fujibayashi, Yasuhisa ^c  

^a Nihon Medi Physics   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

125I FIAU; 125I FITAU; 125I IMBAU; 125I ITAU; 125I ITdU; 125I IUdR

Indexed keywords

5 IODO 1 METHYL(2 DEOXY 2 BROMO BETA DEXTRO ARABINOFURANOSYL)URACIL I 125; 5 IODO 4' THIO 2' DEOXYURIDINE I 125; 5 IODO(2 DEOXY 2 FLUORO 4 THIO BETA DEXTRO ARABINOFURANOSYL)URACIL I 125; 5 IODO(4 THIO 2 BETA DEXTRO ARABINOFURANOSYL)URACIL I 125; FIALURIDINE; GLYCOSIDE; IDOXURIDINE; NUCLEOSIDE ANALOG; RECOMBINANT ENZYME; THYMIDINE KINASE; THYMIDINE PHOSPHORYLASE; TRACER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSOL; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG RETENTION; DRUG SYNTHESIS; DRUG UPTAKE; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; EVALUATION; IMAGING; IN VITRO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; RADIOIODINATION; REDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 10744229063     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(03)00081-7     Document Type: Article

References (22)

1. Asakura J., Robins M.J. Cerium(IV)-medicated halogenation at C-5 of uracil derivatives. J Org Chem. 55:1990;4928-4933.
2. Berk A.J., Clayton D.A. A genetically distinct thymidine kinase in mammalian mitochondria. Exclusive labeling of mitochondrial deoxyribonucleic acid. J Biol Chem. 248:1973;2722-2729.
3. 76Br]bromo-2′ -fluoro-2′-deoxyuridine as a ligand for tumor proliferation: validation in an animal tumor model. Eur J Nucl Med. 29:2000;19-27.
4. 11C-FMAU): Initial clinical studies. J Nucl Med. 43:(suppl 5):2002;26.
5. Wertel L.W., Boder G.B., Kroin J.S., Rinzel S.M., Poore G.A., Todd G.C., Grindey G.B. Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′-deoxycytidine). Cancer Res. 50:1990;4417-4422.
6. Itoh Y., Haraguchi Y., Tanaka H., Gen E., Miyasaka T. Divergent and stereocontrolled approach to the synthesis of uracil nucleosides branched at the anomeric position. J Org Chem. 60:1995;656-662.
7. Johansson N.G., Eriksson S. Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases. Acta Biochemica Polonica. 43:1996;143-160.
8. 76Br]FBAU 3′,5′-dibenzonate as a lipopholic prodrug for brain imaging. Nucl Med Biol. 29:2002;527-535.
9. Kit S., Dubbes D.R., Piekarski L.J., Hsu T.C. Deletion of thymidine kinase activity from L cells resistant to bromodeoxyuridine. Exp Cell Res. 31:1963;297-312.
10. 1H NMR spectroscopy and x-ray crystallography. J Am Chem Soc. 114:1992;9936-9943.
11. 76Br]bromofluorouridine and its validation with regard to uptake, DNA incorporation, and excretion modulation in rats. J Nucl Med. 41:2000;1746-1752.
12. Philips F.S., Feinberg A., Chou T.C., Vidal P.M., Su T.L., Watanabe K.A., Fox J.J. Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-β -D-arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-β -D-arabinofuranosyl)-5-iodocytosine. Cancer Res. 43:1983;3619-3627.
13. Pugmire M.J., Ealick S.E. The crystal structure of pyrimidine nucleoside phosphorylase in a closed conformation. Structure. 6:1998;1467-1479.
14. Rick S.W., Abashkin Y.G., Hilderbrandt R.L., Burt S.K. Computational studies of the domain movement and the catalytic mechanism of thymidine phosphorylase. Prot Struct Func Gen. 37:1999;242-252.
15. Sapse A.M., Snyder G. Ab initio studies of the antiviral drug 1-(2-fluoro-2-deoxy-β-D-arabinofuranosyl)thymine. Cancer Invest. 2:1985;115-121.
16. 18F-FMAU and PET. J Nucl Med. 43:(suppl 5):2002;26.
17. Tanaka H., Miyasaka T. Nucleosides and related compounds which act as inhibitors against replication of HIV-1. Tanpakushitsu Kakusan Koso. 40:1995;1250-1260. Japanese.
18. 125I-iodo-4′ -thio-2′-deoxyuridine as a potential iodinated proliferation marker. J Nucl Med. 43:2002;1218-1226.
19. 211At]astato-1-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) uracil by a halodestannylation reaction. Nucl Med Biol. 25:1998;487-496.
20. Watanabe K.A., Reichman U., Hirota K., Lopez C., Fox J.J. Nucleosides110 synthesis and antiherpes virus activity of some 2′-fluoro-2′ -deoxyarabinofuranosylpyrimidine nucleosides . J Med Chem. 29:1979;21-24.
21. Watanabe K.A., Su T.L., Klein R.S., Chu C.K., Matsuda A., Chun M.W., Lopez C., Fox J.J. Nucleosides. 123. Synthesis of antiviral nucleosides: 5-substituted 1-(2-deoxy-2-halogeno-β-D-arabinofuranosyl)cytosines and -uracils. Some structure-activity relationships. J Med Chem. 26:1983;152-156.
22. Yoshimura Y., Kitano K., Yamada K., Sakata S., Miura S., Ashida N., Machida H. Synthesis and biological activities of 2′-deoxy-2′ -fluoro-4′-thioarabinofuranosylpyrimidine and -purine nucleosides. Bioorg Med Chem. 8:2000;1545-1558.